NCT06810544 2026-04-13Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossTango Therapeutics, Inc.Phase 1/2 Recruiting191 enrolled
NCT02308020 2020-12-19A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainEli Lilly and CompanyPhase 2 Completed162 enrolled 25 charts